Institutional Ownership Taysha Gene Therapies, Inc. (TSHA)
This table provides information about the institutional ownership of Taysha Gene Therapies, Inc. (TSHA). We have compiled data on the 129 institutions that hold shares in the stock, with a total of 150 Million shares, which have been reported (via 13F filing form) to have a value of $273 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
878,448
shares
|
$1.6 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
Palo Alto Investors LP
Palo Alto, CA |
Feb 14, 2025 Q4 2024 |
811,268
shares
|
$1.48 Million
0.22% of portfolio
|
Q1 2024
Added 53.11%
|
|
Quantum Private Wealth, LLC
Lake Forest, IL |
Jan 30, 2025 Q4 2024 |
794,976
shares
|
$1.45 Million
0.46% of portfolio
|
Q4 2024
Added 3.56%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
745,205
shares
|
$1.36 Million
0.0% of portfolio
|
Q4 2024
Reduced 73.94%
|
|
Sands Capital Ventures, LLC
Arlington, VA |
Feb 13, 2025 Q4 2024 |
724,873
shares
|
$1.32 Million
0.48% of portfolio
|
Q3 2021
New holding
|
|
Alphabet Inc.
Mountain View, CA |
Feb 06, 2025 Q4 2024 |
640,882
shares
|
$1.17 Million
0.08% of portfolio
|
Q3 2020
New holding
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
546,414
shares
|
$994,473
0.0% of portfolio
|
Q4 2024
Reduced 3.61%
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Feb 14, 2025 Q4 2024 |
522,500
shares
|
$950,950
0.25% of portfolio
|
Q4 2024
New holding
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
474,257
shares
|
$863,147
0.0% of portfolio
|
Q4 2024
Added 2.46%
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
421,396
shares
|
$766,940
0.0% of portfolio
|
Q4 2024
Added 358.03%
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
335,238
shares
|
$610,133
0.0% of portfolio
|
Q4 2024
Added 35.57%
|
|
Citigroup Inc
|
Feb 12, 2025 Q4 2024 |
253,292
shares
|
$460,991
0.0% of portfolio
|
Q4 2024
Added 91.0%
|
|
Rafferty Asset Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
252,257
shares
|
$459,107
0.0% of portfolio
|
Q4 2024
New holding
|
|
Squarepoint Ops LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
211,842
shares
|
$385,552
0.0% of portfolio
|
Q4 2024
Added 105.43%
|
|
Rhumbline Advisers
Boston, MA |
Jan 30, 2025 Q4 2024 |
192,079
shares
|
$349,583
0.0% of portfolio
|
Q4 2024
Added 3.13%
|
|
Adar1 Capital Management, LLC
Austin, TX |
Feb 13, 2025 Q4 2024 |
177,707
shares
|
$323,426
0.06% of portfolio
|
Q4 2024
Reduced 29.31%
|
|
Jane Street Group, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
169,575
shares
|
$308,626
0.0% of portfolio
|
Q4 2024
Added 57.64%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
151,614
shares
|
$275,937
0.0% of portfolio
|
Q4 2024
New holding
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Feb 14, 2025 Q4 2024 |
151,083
shares
|
$274,971
0.0% of portfolio
|
Q4 2024
Reduced 94.1%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Feb 14, 2025 Q4 2024 |
142,463
shares
|
$259,282
0.0% of portfolio
|
Q4 2024
Reduced 19.28%
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
138,111
shares
|
$251,362
0.0% of portfolio
|
Q4 2024
Reduced 71.58%
|
|
Los Angeles Capital Management LLC
|
Feb 04, 2025 Q4 2024 |
137,460
shares
|
$250,177
0.0% of portfolio
|
Q4 2024
Reduced 33.59%
|
|
Privium Fund Management B.V.
|
Feb 10, 2025 Q4 2024 |
134,900
shares
|
$245,518
0.05% of portfolio
|
Q4 2024
Added 12.42%
|
|
Chicago Partners Investment Group LLC
|
Jan 23, 2025 Q4 2024 |
116,044
shares
|
$211,200
0.01% of portfolio
|
Q4 2024
Reduced 1.8%
|
|
Mirae Asset Global Etfs Holdings Ltd.
Central, K3 |
Feb 14, 2025 Q4 2024 |
108,604
shares
|
$197,659
0.0% of portfolio
|
Q4 2024
Added 23.34%
|